0001477449-23-000049.txt : 20230920 0001477449-23-000049.hdr.sgml : 20230920 20230920160555 ACCESSION NUMBER: 0001477449-23-000049 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230920 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230920 DATE AS OF CHANGE: 20230920 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 231266567 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 8-K 1 tdoc-20230920.htm 8-K tdoc-20230920
FALSE000147744900014774492023-09-202023-09-20

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported) September 20, 2023
___________________________________
Teladoc Health, Inc.
(Exact name of registrant as specified in its charter)
___________________________________

Delaware
(State or other jurisdiction of
incorporation or organization)
001-37477
(Commission File Number)
04-3705970
(I.R.S. Employer Identification Number)
2 Manhattanville Road Suite 203
Purchase, NY 10577
(Address of principal executive offices and zip code)
(203) 635-2002
(Registrant's telephone number, including area code)
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common stock, par value $0.001 per shareTDOCThe New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company    ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective September 20, 2023, the Board of Directors (the “Board”) of Teladoc Health, Inc. (the “Company”) increased the number of directors on the Board to ten and appointed J. Eric Evans as a director of the Company. Mr. Evans was additionally appointed to the compensation committee of the Board. The Board has determined that Mr. Evans is an independent director within the meaning of the New York Stock Exchange listing standards.

There are no arrangements or understandings between Mr. Evans and any other person pursuant to which he was selected as a director. There are no transactions involving the Company and Mr. Evans that the Company would be required to report pursuant to Item 404(a) of Regulation S-K.

Mr. Evans will have the same director indemnification arrangement as do the Company’s other directors appointed since October 2020, the form of agreement for which was filed with the Securities and Exchange Commission (the “SEC”) on March 1, 2021 as Exhibit 10.2 to the Company’s Annual Report on Form 10-K. Mr. Evans will be eligible to participate in the compensation arrangements and programs that are established for the Company’s non-employee directors, as in effect from time to time, which are described in the Company’s Proxy Statement on Schedule 14A filed with the SEC on April 11, 2023.

Item 7.01.    Regulation FD.

On September 20, 2023, the Company issued a press release regarding the matter discussed in Item 5.02 of this Current Report. A copy of the press release is furnished herewith as Exhibit 99.1.

The information furnished under this Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01.    Financial Statements and Exhibits.
(d) Exhibits.

Exhibit No.Description
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).







SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 20, 2023
Teladoc Health, Inc.
By:
/s/ Adam C. Vandervoort
Name:
Adam C. Vandervoort
Title:
Chief Legal Officer and Secretary



 EX-99.1 2 exhibit991.htm EX-99.1 Document
Exhibit 99.1

image_0.jpg

Teladoc Health Appoints Leading Healthcare and Hospitals Executive
Eric Evans to Board of Directors


Purchase, NY, September 20, 2023 – Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company’s board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board’s compensation committee.

David B. Snow, Jr., non-executive Chairman of the company’s board, said: “We are extremely pleased to welcome Eric to Teladoc Health’s board of directors. Eric brings the perfect combination of talent, experience, and mindset to today’s Teladoc Health as we work closely with our clients to enhance our services and offerings, invest in a robust innovation pipeline, and deliver solutions that are transforming healthcare globally.”
Surgery Partners is a leading operator of surgical facilities and ancillary services with more than 180 locations nationwide. During his tenure, beginning in early 2019, Mr. Evans has scaled the business, adding a net 29 new facilities to its portfolio, growing revenue over 50% and earnings over 70%, which has driven approximately $3.5 billion of market capitalization growth. Prior to joining Surgery Partners, Mr. Evans was President of Hospital Operations at Tenet Healthcare, with responsibility for 68 acute care hospitals, 161 hospital-affiliated facilities, and more than 2,200 employed providers. He has a BS in industrial management from Purdue University and an MBA from Harvard Business School.
“It’s a privilege to join the Teladoc Health board of directors and to share my nearly two decades of experience in the integrated healthcare arena,” said Mr. Evans. “I’ve admired Teladoc Health for years and witnessed firsthand the ways in which the company has reinvented healthcare delivery for millions of employers, health plans, governments, and individuals. I look forward to collaborating with my fellow board members and working closely with the management team led by Jason Gorevic to write the next chapter in the company’s evolution.”
Teladoc Health reported second quarter financial results, in July 2023, with strong financial and operating results across all key metrics, including a 10% increase in revenues to $652.4 million and adjusted EBITDA of $72.2 million that exceeded expectations.  Also, in July 2023, Teladoc Health expanded its collaboration in artificial intelligence with Microsoft to address the healthcare workforce crisis. 
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com.

Media:
Chris Stenrud
860-491-8821
pr@teladochealth.com


 EX-101.SCH 3 tdoc-20230920.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 tdoc-20230920_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name EX-101.PRE 5 tdoc-20230920_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image_0.jpg begin 644 image_0.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Sep. 20, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Sep. 20, 2023
Entity Registrant Name Teladoc Health, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-37477
Entity Tax Identification Number 04-3705970
Entity Address, Address Line One 2 Manhattanville Road
Entity Address, Address Line Two Suite 203
Entity Address, City or Town Purchase
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10577
City Area Code 203
Local Phone Number 635-2002
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, par value $0.001 per share
Trading Symbol TDOC
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001477449
XML 8 tdoc-20230920_htm.xml IDEA: XBRL DOCUMENT 0001477449 2023-09-20 2023-09-20 false 0001477449 8-K 2023-09-20 Teladoc Health, Inc. DE 001-37477 04-3705970 2 Manhattanville Road Suite 203 Purchase NY 10577 203 635-2002 false false false false Common stock, par value $0.001 per share TDOC NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.teladoc.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tdoc-20230920.htm tdoc-20230920.xsd tdoc-20230920_lab.xml tdoc-20230920_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tdoc-20230920.htm": { "nsprefix": "tdoc", "nsuri": "http://www.teladoc.com/20230920", "dts": { "inline": { "local": [ "tdoc-20230920.htm" ] }, "schema": { "local": [ "tdoc-20230920.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "tdoc-20230920_lab.xml" ] }, "presentationLink": { "local": [ "tdoc-20230920_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.teladoc.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tdoc-20230920.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tdoc-20230920.htm", "first": true, "unique": true } } }, "tag": { "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.teladoc.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001477449-23-000049-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477449-23-000049-xbrl.zip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end